Protein O-mannosyltransferase activities in lymphoblasts from patients with alpha-dystroglycanopathies.

Protein O-mannosyltransferase activities in lymphoblasts from patients with alpha-dystroglycanopathies. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Protein O-mannosyltransferase activities in lymphoblasts from patients with alpha-dystroglycanopathies. Abstract Text:

Hiroshi Manya,Céline Bouchet,Akiko Yanagisawa,Sandrine Vuillaumier-Barrot,Susana Quijano-Roy,Yasushi Suzuki,Svetlana Maugenre,Pascale Richard,Toshiyuki Inazu,Luciano Merlini,Norma B Romero,France Leturcq,Isabelle Bezier,Haluk Topaloglu,Brigitte Estournet,Nathalie Seta,Tamao Endo,Pascale Guicheney,Hiroshi Manya, Bouchet,Akiko Yanagisawa,Sandrine Vuillaumier-Barrot,Susana Quijano-Roy,Yasushi Suzuki,Svetlana Maugenre,Pascale Richard,Toshiyuki Inazu,Luciano Merlini,Norma B Romero,France Leturcq,Isabelle Bezier,Haluk Topaloglu,Brigitte Estournet,Nathalie Seta,Tamao Endo,Pascale Guicheney,

Defects in O-mannosylation of alpha-dystroglycan cause some forms of congenital muscular dystrophy (CMD), the so-called alpha-dystroglycanopathies. Six genes are responsible for these diseases with overlapping phenotypes. We investigated the usefulness of a biochemical approach for the diagnosis and investigation of the alpha-dystroglycanopathies using immortalized lymphoblasts prepared from genetically diagnosed and undiagnosed CMD patients and from control subjects. We measured the activities of protein O-mannose beta1,2-N-acetylglucosaminyltransferase 1 (POMGnT1) and protein O-mannosyltransferase (POMT). Lymphoblasts from patients harbouring known mutations in either POMGNT1 or POMT1 showed a marked decrease in POMGnT1 or POMT activity, respectively, compared to controls. Furthermore, we identified pathogenic mutations in POMGNT1, POMT1 or POMT2 in six previously genetically uncharacterised patients who had very low enzyme activity. In conclusion, the lymphoblast-based enzymatic assay is a sensitive and useful method (i) to select patients harbouring POMGNT1, POMT1 or POMT2 mutations; (ii) to assess the pathogenicity of new or already described mutations.

Protein O-mannosyltransferase activities in lymphoblasts from patients with alpha-dystroglycanopathies. Publishing Authors By Initials

H Manya,C Bouchet,A Yanagisawa,S Vuillaumier-Barrot,S Quijano-Roy,Y Suzuki,S Maugenre,P Richard,T Inazu,L Merlini,NB Romero,F Leturcq,I Bezier,H Topaloglu,B Estournet,N Seta,T Endo,P Guicheney,H Manya,C Bouchet,A Yanagisawa,S Vuillaumier-Barrot,S Quijano-Roy,Y Suzuki,S Maugenre,P Richard,T Inazu,L Merlini,NB Romero,F Leturcq,I Bezier,H Topaloglu,B Estournet,N Seta,T Endo,P Guicheney,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Protein O-mannosyltransferase activities in lymphoblasts from patients with alpha-dystroglycanopathies. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Neuromuscular disorders : NMD

VOLUME: 18

Page Numbers: 45-51

Journal Abbreviation: Neuromuscul. Disord.

ISSN: 0960-8966

DAY: 14

MONTH: 09

YEAR: 2007

Protein O-mannosyltransferase activities in lymphoblasts from patients with alpha-dystroglycanopathies. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9111470

Protein O-mannosyltransferase activities in lymphoblasts from patients with alpha-dystroglycanopathies. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Protein O-mannosyltransferase activities in lymphoblasts from patients with alpha-dystroglycanopathies. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Protein O-mannosyltransferase activities in lymphoblasts from patients with alpha-dystroglycanopathies.

AFFILIATION: Glycobiology Research Group, Tokyo Metropolitan Institute of Gerontology, Foundation for Research on Aging and Promotion of Human Welfare, Itabashi-ku, Tokyo, Japan.

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Neuromuscul Disord

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Protein O-mannosyltransferase activities in lymphoblasts from patients with alpha-dystroglycanopathies Related Publications

• A novel mutation in the dynamin 2 gene in a Charcot-Marie-Tooth type 2 patient: Clinical and pathological findings.
• Collagen VI status and clinical severity in Ullrich congenital muscular dystrophy: phenotype analysis of 11 families linked to the COL6 loci.
• Drug-induced readthrough of premature stop codons leads to the stabilization of laminin alpha2 chain mRNA in CMD myotubes.
• Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onset.
• Protein O-mannosyltransferase activities in lymphoblasts from patients with alpha-dystroglycanopathies.
• The occurrence of Brugada syndrome and isolated cardiac conductive disease in the same family could be due to a single SCN5A mutation or to the accidental association of both diseases.